Lipoprotein-associated estrogens

Cardiovascular Research

Volumn 56, Issue 2, 2002, Pages 184-188

  Tikkanen, Matti J ^a   Vihma, Veera ^a   Jauhiainen, Matti ^b   Höckerstedt, Anna ^a   Helisten, Hannamaarit ^a   Kaamanen, Maija ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Atherosclerosis; Hormones; Lipoproteins; Membrane transport

Indexed keywords

5,5' DITHIOBIS(2 NITROBENZOIC ACID); ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; ESTRADIOL; ESTROGEN; FATTY ACID ESTER; HORMONE DERIVATIVE; ISOFLAVONE; LIPOPROTEIN; LIPOPROTEIN RECEPTOR; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHYTOESTROGEN; PROBUCOL; STEROID; UBIQUINONE;

ADIPOSE TISSUE; ANALYTIC METHOD; BODY FLUID; CELL PROTECTION; DRUG MECHANISM; HORMONE ACTION; HORMONE TRANSPORT; HUMAN; OXIDATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW;

ANTIOXIDANTS; ARTERIOSCLEROSIS; ESTERIFICATION; ESTERS; ESTROGENS; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL;

EID: 0036839139     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00535-7     Document Type: Review

References (42)

1. Tikkanen M.J. Sex hormones. Betteridge J., Illingworth R., Shepherd J., Lipoproteins in health and disease. 1999;967-984 Hodder and Stoughton, London.
2. Lamon-Fava S., Fisher E.C., Nelson M.E., et al. Effect of exercise and menstrual cycle status on plasma lipids, low density lipoprotein particle size and apolipoproteins. J Clin Endocr Metab. 68:1989;17-21.
3. Friday K.E., Drinkwater B.L., Bruemmer B., Chesnut C. 3rd, Chait A. Elevated plasma low-density lipoprotein and high-density lipoprotein levels in amenorrheic athletes: effects of endogenous hormone status and nutrient intake. J Clin Endocr Metab. 77:1993;1605-1609.
4. Woods M., Schaefer E.J., Morrill A., et al. Effect of menstrual cycle phase on plasma lipids. J Clin Endocrinol Metab. 65:1987;321-323.
5. Tikkanen M.J., Kuusi T., Nikkilä E.A., Stenman U.H. Variation of postheparin plasma hepatic lipase by menstrual cycle. Metabolism. 35:1986;99-104.
6. Demacker P.N., Schade R.W., Stalenhoef A.F., Stuyt P.M., van't Laar A. Influence of contraceptive pill and menstrual cycle on serum lipids and high-density lipoprotein cholesterol concentrations. Br Med J. 284:1982;1212-1215.
7. Ayres S., Tang M., Subbiah M.T. Estradiol-17β as an antioxidant: some distinct features when compared with common fat-soluble antioxidants. J Lab Clin Med. 128:1996;367-375.
8. Rifici V.A., Khachadurian A.K. The inhibition of low-density lipoprotein oxidation by 17β estradiol. Metabolism. 41:1992;1110-1114.
9. Maziere C., Auclair M., Ronveaux M.F., et al. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein. Atherosclerosis. 89:1991;175-182.
10. Nakano M., Sugioka K., Naito I., Takekoshi S., Niki E. Novel and potent biological antioxidants on membrane phospholipid peroxidation: 2-hydroxy estrone and 2-hydroxy estradiol. Biochem Biophys Res Commun. 142:1987;919-924.
11. Ruiz-Larrea M.B., Leal A.M., Liza M., Lacort M., de Groot H. Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids. 59:1994;383-388.
12. Miller C.P., Jirkovsky I., Hayhurst D.A., Adelman S.J. In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids. 61:1996;305-308.
13. Mukai K., Daifuku K., Yokoyama S., Nakano M. Stopped-flow investigation of antioxidant activity of estrogens in solution. Biochim Biophys Acta. 1035:1990;348-352.
14. Tikkanen M.J., Adlercreutz H. Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention? Biochem Pharmacol. 60:2000;1-5.
15. Jones D.L., James V.H.T. The identification, quantification and possible origin of nonpolar conjugates in human plasma. J Steroid Biochem. 22:1985;243-247.
16. Mellon-Nussbaum S., Ponticorvo L., Schatz F., Hochberg R.B. Estradiol fatty acid esters: the isolation and identification of the lipoidal derivative of estradiol synthesized in the bovine uterus. J Biol Chem. 257:1982;5678-5684.
17. Larner J.M., Pahuja S.L., Shackleton C.H., et al. The isolation and characterization of estradiol fatty acid esters in human ovarian follicular fluid. Identification of an endogenous long-lived and potent family of estrogens. J Biol Chem. 268:1993;13893-13899.
18. Hochberg R.B. Biological esterification of steroids. Endocr Rev. 19:1998;331-348.
19. Meng Q.H., Hockerstedt A., Heinonen S., et al. Antioxidant protection of lipoproteins containing estrogens: in vitro evidence for low- and high-density lipoproteins as estrogen carriers. Biochim Biophys Acta. 1439:1999;331-340.
20. Tang M., Abplanalp W., Ayres S., Subbiah M.T. Superior and distinct antioxidant effects of selected estrogen metabolites on lipid peroxidation. Metabolism. 45:1996;411-414.
21. Shwaery G.T., Vita J.A., Keaney J.F. Jr. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol. Requirement for estradiol modification. Circulation. 95:1997;1378-1385.
22. Shwaery G.T., Vita J.A., Keaney J.F. Jr. Antioxidant protection of LDL by physiologic concentrations of estrogens is specific for 17β-estradiol. Atherosclerosis. 138:1998;255-262.
23. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med. 22:1997;749-760.
24. Cook N.C., Samman S. Flavonoids - chemistry, metabolism, cardioprotective effects, and dietary sources. J Nutr Biochem. 7:1996;66-76.
25. Wei H., Bowen R., Cai Q., Barnes S., Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol. 208:1995;124-130.
26. Hodgson J.M., Croft K.D., Puddey I.B., Mori T.A., Beilin L.J. J Nutr Biochem. 7:1996;664-669.
27. Tikkanen M.J., Wahala K., Ojala S., Vihma V., Adlercreutz H. Effect of soybean phytoestrogen intake on low density lipoprotein oxidation resistance. Proc Natl Acad Sci. 95:1998;3106-3110.
28. Kanazawa T., Osanai T., Zhang X.S., et al. Protective effects of soy protein on the peroxidizability of lipoproteins in cerebrovascular diseases. J Nutr. 125:1995;639S-646S.
29. Meng Q.-H., Lewis P., Wähälä K., Adlercreutz H., Tikkanen M.J. Incorporation of esterified soybean isoflavones with antioxidant activity into low density lipoprotein. Biochim Biophys Acta. 1438:1999;369-376.
30. Kuohung W., Shwaery G.T., Keaney J.F. Jr. Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cells. Am J Obstet Gynecol. 184:2001;1060-1063.
31. Pahuja S.L., Kim A.H., Lee G., Hochberg R.B. Origin of estradiol fatty acid esters in human ovarian follicular fluid. Biol Reprod. 52:1995;625-630.
32. Helisten H., Höckerstedt A., Wähälä K., et al. Accumulation of high-density lipoprotein-derived estradiol-17β fatty acid esters in low-density lipoprotein particles. J Clin Endocr Metab. 86:2001;1294-1300.
33. Larner J., Shackleton C., Roitman E., Schwartz P., Hochberg R. Measurement of estradiol-17-fatty acid esters in human tissues. J Clin Endocrinol Metab. 75:1992;195-200.
34. Janocko L., Hochberg R. Estradiol fatty acid esters occur naturally in human blood. Science. 222:1983;1334-1336.
35. Vihma V., Adlercreutz H., Tiitinen A., et al. Quantitative determination of estradiol fatty acid esters in human pregnancy serum and ovarian follicular fluid. Clin Chem. 47:2001;1256-1262.
36. Witztum J.L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 88:1991;1785-1792.
37. Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res. 32:1991;1325-1332.
38. Ruiz-Sanz J.I., Navarro R., Martinez R., et al. 17β-Estradiol affects in vivo the low density lipoprotein composition, particle size, and oxidizability. Free Radic Biol Med. 31:2001;391-397.
39. Roy R., Belanger A. Elevated levels of endogenous pregnenolone fatty acid esters in follicular fluid high density lipoproteins support progesterone synthesis in porcine granulosa cells. Endocrinology. 131:1992;1390-1396.
40. Provencher P.H., Roy R., Belanger A. Pregnenolone fatty acid esters incorporated into lipoproteins: substrates in adrenal steroidogenesis. Endocrinology. 130:1992;2717-2724.
41. Roy R., Belanger A. ZR-75-1 breast cancer cells generate nonconjugated steroids from low-density lipoprotein-incorporated lipoidal dehydroepiandrosterone. Endocrinology. 133:1993;683-689.
42. Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand J Clin Lab Invest. 50:1990;3-23.